Novavax Inc. Reports Q1 2026 Financial Results

What Happened

• On May 6, 2026, Novavax, Inc. announced its financial results for the quarter ended March 31, 2026 via a press release. The company filed a Current Report on Form 8-K (Item 2.02) to disclose the results and attached the press release as Exhibit 99.1.

Key Details

• Filing date: May 6, 2026 (Form 8-K filed with the SEC).
• Reporting period: Quarter ended March 31, 2026.
• Disclosure format: Press release attached as Exhibit 99.1; cover page interactive data provided as Inline XBRL (Exhibit 104).
• Item reported on the 8-K: 2.02 (Results of Operations and Financial Condition).

Why It Matters

• This 8-K signals Novavax has publicly released its quarterly earnings/financial results; investors should read the attached press release for specific metrics such as revenue, net income or loss, cash position and any management commentary or guidance. The filing itself does not include the numeric results—those details are in the attached press release (Exhibit 99.1).